ICS 2017 Scientific Podium Short Oral Session S18

Female Pelvic Floor 3

Scientific Podium Short Oral Session S18

Speakers
	Wednesday 13th September 2017
	16:30 - 18:00
	Spadolini F Capacity: 200
N Nucelio L B M Lemos ICS Chair A Andrea Braga ICS Chair

Session Schedule

16:30

#306 What is the best cut-off value for the levator- urethra gap measurement in the diagnosis of avulsion defects?

Eisenberg V¹, Vernikovsky G¹, Lantsberg D¹, Bitman G¹, Alcalay M¹
1. Sheba Medical Center
Anatomy, Female, Mathematical or statistical modelling, Imaging, Pelvic Organ Prolapse

16:37

#307 EFFECT OF THE PLATELET-RICH PLASMA COATING OF IMPLANTED POLYPROPYLENE MESHES ON ABDOMINAL ADHESIONS AND OXIDATIVE STRESS IN IN RABBITS

Belebecha V¹, Casagrande R¹, Urbano M¹, Alves S¹, Mathiel D¹, Martinez R¹, Valle D¹, Almeida S H¹
1. Universidade Estadual de Londrina
Basic Science, Grafts: Synthetic, Pelvic Organ Prolapse, Pathophysiology

16:45

#308 Urinary incontinence in the Netherlands: prevalence and associated risk factors in adults and children

Linde M¹, Nijman R¹, Trzpis M¹, Broens P¹
1. University Medical Center Groningen
Female, Incontinence, Male, Pediatrics, Questionnaire

16:52

#309 The anatomic urethral length is correlated with urodynamic parameters and results of anti-incontinence surgery in women with stress urinary incontinence

Kim M K¹, Kim Y G¹, Shin Y S¹, You J H¹
1. Chonbuk National University Hospital
Female, Stress Urinary Incontinence, Anatomy

17:00

#310 Prevalence rates of bladder outlet obstruction and detrusor underactivity and their urodynamic and clinical findings in women with ≥stage II cystocele

Lin H¹, Chang T², Chen C², Wu W¹, Hsiao S¹
1. Far Eastern Memorial Hospital, Banqiao, New Taipei, Taiwan, 2. National Taiwan University Hospital, Taipei, Taiwan
Detrusor Hypocontractility, Bladder Outlet Obstruction , Pelvic Organ Prolapse, Voiding Diary, Urgency/Frequency

17:07

#311 Does Gabapentin Reduce Opioid Use Postoperatively? (“GROUP Study”): A randomized control trial in women undergoing reconstructive pelvic surgery

Li A¹, Wadsworth K¹, Siddiqui N¹, Alarab M¹, McDermott C¹, Lemos N¹, Lovatsis D¹
1. Mount Sinai Hospital
Female, Pain, other, Surgery, Pelvic Organ Prolapse

17:15

#312 Hypopressive Abdominal Technique or Transversus Abdominis muscle contraction?: Differences in activation of the pelvic floor muscles and intra-abdominal pressure.

París Zamora I¹, Pérez Mallada N¹, Coronado Martín P J²
1. Pontifical Comillas University, 2. José Botella LLusiá Woman Health Institute of San Carlos Clinical Hospital
Biomechanics, Pelvic Floor, Physiotherapy, Prevention

17:22

#313 Low Incidence of Clean Intermittent Catheterisation With OnabotulinumtoxinA in Diverse Age Groups of Overactive Bladder Patients With Corresponding Improvements in Urinary Symptoms, Treatment Response, and Quality of Life

Nitti V¹, Drake M², Everaert K³, Rovner E⁴, Dmochowski R⁵, Ginsberg D⁶, Radomski S⁷, Aboushwareb T⁸, Chang C⁹, Chapple C¹⁰
1. New York University Langone Medical Center, New York, NY, USA, 2. Bristol Urological Institute, Bristol, UK, 3. Ghent University Hospital, Ghent, Belgium, 4. Medical University of South Carolina, Charleston, SC, USA, 5. Vanderbilt University Medical Center, Nashville, TN, USA, 6. USC Institute of Urology, Los Angeles, CA, USA, 7. University of Toronto, Toronto, Canada, 8. Allergan plc, Irvine, CA, USA, 9. Allergan plc, Bridgewater, NJ, USA, 10. The Royal Hallamshire Hospital, Sheffield Teaching Hospitals, NHS Foundation Trust, Sheffield, UK
Overactive Bladder, Clinical Trial, Incontinence, Detrusor Overactivity, Quality of Life (QoL)

17:30

#314 Assessing persistence in patients with overactive bladder prescribed mirabegron in routine clinical practice: subanalysis of a pan-European non-interventional study

Foley S¹, Freeman R², Rosa J³, Vicente E⁴, Huang M⁵, Stari A⁵, Bowditch S⁵, Choudhury N⁵
1. Royal Berkshire Hospital, Reading, UK, 2. Derriford Hospital, Plymouth, Devon, UK, 3. Department of Urology, Hospital Comarcal Santiago Apóstol, Miranda de Ebro-Burgos, Spain, 4. Urology Department, Parc Taulí Sabadell Hospital Universitari, Sabadell, Barcelona, Spain, 5. Astellas Pharma Europe Ltd, Chertsey, UK
Overactive Bladder, Incontinence, Quality of Life (QoL)

17:37

#315 A systematic review and meta-analysis on the efficacy and safety of Mirabegron 50 mg and 100 mg vs. Tolterodine and Placebo for Overactive Bladder/Storage LUTS.

Sebastianelli A¹, Russo G I², Cimino S², Salvi M¹, Spatafora P¹, Tasso G¹, Carini M¹, Serni S¹, Moncada I³, Gravas S⁴, Giuliano F⁵, Gacci M¹
1. Department of Urology, Careggi Hospital, University of Florence (Italy), 2. Department of Urology, Policlinico Hospital, University of Catania, Catania, Italy, 3. Department of Urology, Hospital La Zarzuela, Madrid, Spain, 4. Department of Urology, University Hospital of Larissa, Larissa, Greece, 5. AP-HP, Neuro-Uro-Andrology, Versailles Saint Quentin en Yvelines University, Versailles, France
Incontinence, Overactive Bladder, Urgency/Frequency, Pharmacology

17:45

#316 Functional role of Transient Receptor Potential Melastatin 8 (TRPM8) channel in the rat urinary bladder assessed by using a novel potent antagonist

Aizawa N¹, Ohshiro H², Watababe S², Homma Y³, Igawa Y¹
1. Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, 2. RaQualia Pharma Inc., 3. Department of Urology, The University of Tokyo Graduate School of Medicine
Basic Science, Physiology, Pharmacology

17:52

#317 THE EFFECT OF ORAL PHENAZOPYRIDINE ON POSTOPERATIVE VOIDING AFTER MID-URETHRAL SLINGS (EPIPHANY STUDY)

Dueñas Garcia O¹, Sierra T¹, Taylor D¹, Leung K¹, Hall C¹, Flynn M¹
1. University of Massachusetts
Clinical Trial, Female, Voiding Dysfunction , Stress Urinary Incontinence